Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Hui Zhang
Observed names:
H X Zhang,
Zhang, Hui
Institutions:
Shanghai Medical College of Fudan University,
Army Medical University,
Fudan University,
Fudan University Shanghai Cancer Center,
Shanghai Clinical Research Center
Observed institutions:
Shanghai Medical College of Fudan University,
Army Medical University,
Fudan University,
Fudan University Shanghai Cancer Center,
Zhongshan Hospital,
Shanghai Clinical Research Center
show all 6
ORCID:
0000-0003-4753-2437
Observed ORCID:
0000-0003-4753-2437
OpenAlex ID:
A5123479462
[Efficacy and safety of combination therapy with chemotherapy, programmed death-1 inhibitor and anlotinib in the treatment of advanced dedifferentiated liposarcoma].
2022
·
X Guo
, R Y Zhuang
, et al.
·
PubMed
·
3
Effectiveness and Safety of Atezolizumab Plus Bevacizumab in Unresectable Hepatocellular Carcinoma: A Multicenter, Retrospective Real-World Study in China
2026
·
Minghua Shao
, Binbin Tan
, et al.
·
Clinical Medicine Insights Oncology
·
2
Neoadjuvant immunotherapy combined with radiochemotherapy vs chemotherapy alone in pMMR colon cancers: The TORCH-C randomized phase 2 clinical trial.
2026
·
Hui Zhang
, Yaqi Li
, et al.
·
Journal of Clinical Oncology
·
1
Comparison of Thrombocytopenia and Splenomegaly in Locally Advanced Rectal Cancer Patients Receiving Total Neoadjuvant Therapy With and Without Immunotherapy
2026
·
Shuwen Li
, Mingxu Yan
, et al.
·
Cancer Medicine
Integrating clinical and genomic features to predict response to neoadjuvant therapy in microsatellite-stable rectal cancer
2026
·
Lijie Zhang
, Jingwen Wang
, et al.
·
Therapeutic Advances in Medical Oncology
Radiotherapy followed by CAPOX plus tislelizumab in microsatellite-stable rectal cancer with synchronous resectable metastases: Updated results of the MIRACLE-1 study.
2026
·
Menglong Zhou
, Zezhi Shan
, et al.
·
Journal of Clinical Oncology
Radiotherapy followed by systemic therapy and tislelizumab in microsatellite-stable rectal cancer with synchronous unresectable metastases: Updated results of the MIRACLE-2 study.
2026
·
Menglong Zhou
, Lijun Shen
, et al.
·
Journal of Clinical Oncology
Immunotherapy-based total neoadjuvant therapy with or without short-course radiotherapy for locally advanced rectal cancer: Preliminary results of TORCH-iTNT.
2026
·
Yaqi Wang
, Lijun Shen
, et al.
·
Journal of Clinical Oncology
Neoadjuvant short-course radiotherapy combined with CAPOX and PD-1 inhibitor for MSS/pMMR high-risk locally advanced colon cancer: A randomized, prospective, multicentre, phase II trial (TORCH-C).
2026
·
Hui Zhang
, Fan Xia
, et al.
·
Journal of Clinical Oncology
PDF
Show more works
View as search
Works count:
10
Citation count:
6
H-index:
2
I10-index:
Year
Topic
Type